{
    "title": "Teva's 2017 revenue, profit forecasts miss as launch delays weigh",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4095306/Tevas-2017-revenue-profit-forecasts-miss-launch-delays-weigh.html",
    "date": "2017-01-06",
    "keywords": [
        "revenue",
        "profit",
        "grover",
        "drug",
        "company",
        "business",
        "year",
        "tevas",
        "gmt",
        "divya",
        "forecast",
        "product",
        "vigodman",
        "copaxone",
        "sector",
        "share",
        "launch",
        "email",
        "groverjan",
        "maker",
        "percent",
        "fridayteva",
        "percentage",
        "price",
        "erosion",
        "yearteva",
        "investigation",
        "pricefixing",
        "mylan",
        "nv",
        "plc",
        "forecasttevas",
        "projection",
        "expectation",
        "executive",
        "erez",
        "conference",
        "callthe",
        "outlook",
        "capital",
        "analyst",
        "saidon",
        "dependency",
        "launchesteva",
        "milligram",
        "dose",
        "flagship",
        "sclerosis",
        "competition",
        "yearunder",
        "assumption",
        "entry",
        "february",
        "cents80",
        "guidance",
        "degradation",
        "contribution",
        "leerink",
        "gerberry",
        "saidteva",
        "half",
        "month",
        "officials2016",
        "transition",
        "healthcare",
        "hit",
        "exchange",
        "average",
        "thomson",
        "point",
        "rbcs",
        "stanicky",
        "reporting",
        "bengaluru",
        "editing",
        "chakrabarty",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}